Phosphodiesterase Type 5 Inhibitors: A Biochemical and Clinical Correlation Survey

International Journal of Impotence Research - United Kingdom
doi 10.1038/sj.ijir.3901067
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

AB030. Evolution of Phosphodiesterase Type 5 Inhibitors

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Phosphodiesterase Type 5 Inhibitors in the Treatment of Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Phosphodiesterase-5 Inhibitors: Emerging Nephroprotective Drugs

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

Daily Use of Phosphodiesterase Type 5 Inhibitors as Prevention for Recurrent Priapism

Revista da Associacao Medica Brasileira
Medicine
2017English

Phosphodiesterase-5 Inhibitors and Colorectal Cancer: A New Frontier for Prevention?

Gastroenterology
HepatologyGastroenterology
2019English

Usage and Perceptions of Phosphodiesterase Type 5 Inhibitors Among the Male Partners of Infertile Couples

Clinical and Experimental Reproductive Medicine
Reproductive Medicine
2016English

Quantitative Risk-Benefit Analysis of Oral Phosphodiesterase Type 5 Inhibitors on Erectile Dysfunction Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models

PLoS ONE
Multidisciplinary
2010English

Phenanthrenes From Eulophia Macrobulbon as Novel Phosphodiesterase-5 Inhibitors

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy